mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |